Neoplasms

Digestive System Diseases

All Conditions

Colorectal Neoplasms

Intestinal Neoplasms

Gastrointestinal Neoplasms

Digestive System Neoplasms

Gastrointestinal Diseases

Colonic Diseases

Intestinal Diseases

Rectal Diseases

Subjects will receive two packs of placebo ONS (ONS_320275) orally daily

Subjects will receive two packs of test ONS (ONS_211567) orally daily

Subjects will consume two packs (165ml/pack) of placebo ONS (ONS_320275) orally daily at any time of day.

ONS_320275

Subjects will consume two packs (165ml/pack) of test ONS (ONS_211567) orally daily at any time of day.

ONS_211567

Joo Hyun Park

Seunggyu Yoon

Ingyu Lee

The goal of this clinical trial is to find usefulness of balanced high protein supplementation on muscle function recovery and clinical outcomes after chemotherapy.

Participants will intake test or placebo oral nutritional supplements. Researchers will compare test groups and placebo groups to see if test oral supplements are more useful in muscle function recovery and clinical outcomes.

Usefulness of Balanced High Protein Supplementation on Recovery and Clinical Outcomes After Chemotherapy

Usefulness of Balanced High Protein Supplementation on Recovery and Clinical Outcomes After Chemotherapy: Randomized, Parallel, Double-blind, Placebo-controlled Trial

Skeletal Muscle analysis is performed using BIA.

Muscle reduction is determined by the researcher through SMM, HGS, and SPPB test results.

Skeletal muscle mass (SMM) analysis is performed using BIA.

Handgrip strength (HGS) is an indicator of muscle strength.

Short physical performance battery (SPPB) is a multi-function evaluation that combines three useful and easy-to-measure objective functional evaluation methods.

Common Terminology Criteria for Adverse Events (CTCAE) is widely accepted as the standard classification and severity grading scale for adverse events in cancer therapy, clinical trials and other oncology settings. Version 5.0 is the most updated document.

Incidence of chemotherapy modification is classified into delayed administration, dose reduction, and administration termination of anticancer drugs, and investigated on a dichotomy scale (existence or absence).

Detection and quantification of immunity indicators in blood samples drawn from a vein : Interleukin-6 (IL-6), Interleukin 10 (IL-10), Interleukin 17 (IL-17), Interleukin-2 (IL-2), Interleukin-12 (IL-12), Interferon gamma (IFN-γ), Tumor necrosis factor-alpha (TNF-α)

Nutritional status evaluation and intake evaluation (PG-SGA) is a tool that expresses nutritional status. It is divided into continuous and categorical variables. In continuous variable, 0 to 1 point is said to be good according to the total score, and 2 to 3, 4 to 8, and 9 or more points are evaluated as 3 phases of malnutrition. In categorical variable, it consists of three types: A, B, and C, and the results deteriorate in order.

Quality of life (EORTC QLQ-C30) is developed to assess the quality of life of cancer patients. Each questions 1 through 28 have a maximum of 4 point and a minimum of 1 point, and each questions 29 through 30 have a maximum of 7 point and a minimum of 1 point. The former means higher scores is worse results, and the latter means higher scores is better results. The total score is 0 to 100 points.

Simplified nutritional appetite questionnaire (SNAQ) is a simple appetite scale assessment tool that has been validated to predict weight loss in cancer patients. Including all the questions, each question's maximum score is 5 point and the minimum score is 1 point. A lower score means worse results. The total score is 4 to 20 points.

Oral nutritional supplement (ONS) sensory evaluation is sensuality evaluation of test or control products.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Usefulness of Balanced High Protein Supplementation on Recovery and Clinical Outcomes After Chemotherapy	NCT05938504	Colorectal Neop...	ONS_320275 ONS_211567	19 Years -	Daesang Wellife
Usefulness of Balanced High Protein Supplementation on Recovery and Clinical Outcomes After Chemotherapy	NCT05938504	Colorectal Neop...	ONS_320275 ONS_211567	19 Years -	Daesang Wellife
Usefulness of Balanced High Protein Supplementation on Recovery and Clinical Outcomes After Chemotherapy	NCT05938504	Colorectal Neop...	ONS_320275 ONS_211567	19 Years -	Daesang Wellife
Usefulness of Balanced High Protein Supplementation on Recovery and Clinical Outcomes After Chemotherapy	NCT05938504	Colorectal Neop...	ONS_320275 ONS_211567	19 Years -	Daesang Wellife

Spots Global Cancer Trial Database for ons 211567

Every month we try and update this database with for ons 211567 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Spots Global Cancer Trial Database for ons 211567

Every month we try and update this database with for ons 211567 cancer trials from around the world to help patients and their families find trials that might be right for them. We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Every month we try and update this database with for ons 211567 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.